Compare NEOG & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | RXRX |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1995 | 2021 |
| Metric | NEOG | RXRX |
|---|---|---|
| Price | $9.62 | $3.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $10.67 | $7.50 |
| AVG Volume (30 Days) | 1.8M | ★ 22.0M |
| Earning Date | 04-09-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $894,661,000.00 | $74,681,000.00 |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | $487.50 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $4.56 | $2.77 |
| 52 Week High | $11.43 | $7.18 |
| Indicator | NEOG | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 52.21 |
| Support Level | $8.43 | $2.88 |
| Resistance Level | $10.30 | $4.01 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 85.09 | 48.00 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.